Private limited company · Gent · incorporated on 28/01/2021 · 5,2 ETP
| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | 104,3 k € | +490.0% | 17,7 k € | -60.3% | 44,5 k € | +341.9% | -18,4 k € | |
| EBITDA | -530,8 k € | -36.6% | -388,5 k € | -55.5% | -249,9 k € | -262.1% | -69,0 k € | |
| Operating profit | -605,9 k € | -43.7% | -421,7 k € | -61.2% | -261,6 k € | -278.9% | -69,0 k € | |
| Profit/loss | -631,6 k € | -38.1% | -457,2 k € | -64.3% | -278,3 k € | -296.4% | -70,2 k € | |
| Equity | -225,3 k € | -155.5% | 406,3 k € | +220.7% | -336,5 k € | -478.1% | -58,2 k € | |
| Total assets | 709,6 k € | -55.1% | 1,6 M € | +177.6% | 569,6 k € | +2615.9% | 21,0 k € | |
| Cash | 350,8 k € | -69.0% | 1,1 M € | +2413.3% | 45,1 k € | +228.7% | 13,7 k € | |
| Debts | 855,7 k € | -27.2% | 1,2 M € | +29.6% | 906,2 k € | +1044.3% | 79,2 k € | |
| Staff | 5,2 | 3,5 | 2,8 | — | ||||
Private limited company loss-making in the latest fiscal year. Cash position declining (-69.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
272BIO is a Private limited company incorporated in 2021. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Gent. It employs on average 5,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette